Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-15

Clinical Trial Update: Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of diclofenac sodium topical gel 1% applied four times daily for acute ankle sprain; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • diclofenac sodium topical gel, 1% (diclofenac sodium topical gel, 1%)

Snippet

Sponsor: Novartis | Conditions: Acute Ankle Sprain | Phase 3 | Status: COMPLETED | Results posted: 2013-01-15